Repligen | RGEN - Loan Capital



Repligen reported $533.72M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Agilent USD 3.35B 1000K Jul/2025
Align Technology USD 0 0 Dec/2024
Bio Techne USD 346M 16M Jun/2025
BioMarin Pharmaceutical USD 596.16M 512K Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Bruker USD 2.38B 303.5M Jun/2025
Charles River Laboratories USD 2.33B 178.38M Jun/2025
Danaher USD 16.85B 877M Jun/2025
Dentsply International USD 2.22B 625M Jun/2025
Exact Sciences USD 2.32B 9.48M Jun/2025
General Electric Aerospace USD 17B 489M Jun/2025
Henry Schein USD 2.09B 122M Jun/2025
Illumina USD 1.49B 1000K Jun/2025
IQVIA Holdings USD 14.18B 1.07B Jun/2025
Mettler Toledo International USD 2.12B 232.49M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pfizer USD 57.5B 137M Jun/2025
Repligen USD 533.72M 4.12M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Standard Biotools USD 299K 0 Jun/2025
Thermo Fisher Scientific USD 33.02B 1.64B Jun/2025
Waters USD 1.2B 159.76M Jun/2025
West Pharmaceutical Services USD 202.6M 0 Jun/2025